Senior BD Manager – Portfolio Strategy

This role sits at the core of our growth strategy, leading the end-to-end evaluation of new therapeutic opportunities from early ideation through full due diligence and launch readiness.

The position plays a critical role in shaping the future portfolio, identifying and assessing new molecules, innovative technologies, and early-stage opportunities in close collaboration with R&D, Medical Affairs, Regulatory, Quality, Finance, and academic partners.

Key impact of the role:

• Lead ideation initiatives, focus groups, and design-thinking workshops to generate actionable market and scientific insights
• Build, validate, and continuously refine business cases including market sizing, pricing, revenue forecasts, and “right-to-win” assessments
• Coordinate cross-functional due diligence across technical, regulatory, quality, medical, and financial domains
• Translate scientific and clinical insights into clear go / no-go investment recommendations
• Act as a strategic bridge between science, innovation, and business decision-making
• Provide executive-level updates on risks, assumptions, and portfolio impact through launch preparation

Professional Experience

• 10+ years of experience in pharmaceutical business development, portfolio strategy, new product planning, or corporate strategy
• Proven experience building and refining business cases from early ideation through full due diligence
• Hands-on experience coordinating cross-functional due diligence involving R&D, Regulatory Affairs, Quality (QA/QC), Medical Affairs, Finance, and Operations
• Demonstrated exposure to early-stage opportunities, new molecules, innovative technologies, or therapeutic area expansion
• Experience working with R&D teams, Medical Affairs, and academic or scientific institutions